The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.

“Gilead has confirmed to us its intention to support manufacturing in South Africa,” Unitaid director of program Robert Matiru told BioProcess Insider. “This initiative will help identify capable ...

Eppendorf experts discuss regulatory challenges, single-use technologies, and digitalization strategies for scaling from R&D to commercial manufacturing.

Last month, large pharmaceutical conglomerate Merck filed a worker adjustment and retraining notification (WARN) notice with ...

A research team from London examined the relationship between adenovirus-associated virus (AAV)-based vectors and liver ...

Explore the latest news and expert commentary by Lakshmana Kumar Arlagadda, brought to you by the Contributor of BioProcess ...

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Facility commissioning and qualification (C&Q) success begins with project setup meetings that align stakeholders, project metrics, and mitigate risks.

Swiss multinational pharmaceutical company Novartis announced that it will build a radioligand therapy (RLT) manufacturing facility in Denton, Texas. The facility will be 46,000 square feet, joining ...

IDBS Polar unifies ELN, LIMS, and LES in one GxP-ready platform, transforming lab data into AI-ready insights across the entire product lifecycle.

Figure 1A: Antibody–drug conjugate (ADC) structure and delivery pathways; linker chemistry determines the mechanism by which cytotoxin release occurs. This schematic shows a monoclonal antibody (MAb) ...